Kineta
Seattle, US · Washington corporation · 1 known investors
Find your way into Kineta
16 people in our graph share verified history with the Kineta team — schools, employers, funds. One of them is your warm intro.
Troy Cichosunlockedknows Pauline Kenny · together at Seattle University School of Law
×11knows the team · via Seattle University School of Law
Founders & leadership
SI
Shawn IadonatoinFounder
RH
Robert HedequistExecutive
PK
Pauline KennyinExecutivePauline Kenny is an executive officer at Kineta with a legal background spanning contract negotiations, corporate governance, regulatory compliance, and intellectual property matters.
CM
Charles MagnessNamed on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements$86.2M disclosed across 18 rounds · 2014–2022
▶$17.4MraisedJun 2022 · 19 investors · BiotechnologyRule 506(b)
▶$17.4MraisedJun 2022 · 19 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Shawn ladonatoExecutive Officer, Director
- Craig PhilipsExecutive Officer
- Marion R. FooteDirector
- Don MerlinoDirector
- Richard SamuelsonDirector
- Jiyoung HwangDirector
- Steven MitchellDirector
- Raymond BartoszekDirector
- Pauline KennyExecutive Officer
- Offering amount
- $27.3M
- Amount sold
- $17.4M
- Sales commissions
- $900K
- Placement agents
- Alta Companies Ltd.
- First sale
- May 2021
- Incorporated
- Corporation, Washington
- Federal exemptions
- 06b
▶$2.4MraisedMar 2022 · 1 investors · BiotechnologyRule 506(b)
▶$2.4MraisedMar 2022 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Don MerlinoDirector
- Craig PhilipsExecutive Officer
- Raymond BartoszekDirector
- Marion R. FooteDirector
- Shawn ladonatoExecutive Officer, Director
- Richard SamuelsonDirector
- Kyungwon OhDirector
- Pauline KennyExecutive Officer
- Steven MitchellDirector
- Offering amount
- $15M
- Amount sold
- $2.4M
- Sales commissions
- $256K
- Placement agents
- Alta Companies Ltd.
- First sale
- Feb 2022
- Incorporated
- Corporation, Washington
- Federal exemptions
- 06b
▶$1.2MraisedJul 2021 · 11 investors · BiotechnologyRule 506(b)
▶$1.2MraisedJul 2021 · 11 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Marion FooteDirector
- Richard SamuelsonDirector
- Don MerlinoDirector
- Steven MitchellDirector
- Shawn ladonatoExecutive Officer, Director
- Kevin OhDirector
- Raymond BartoszekDirector
- Pauline KennyExecutive Officer
- Craig PhilipsExecutive Officer
- Offering amount
- $3.8M
- Amount sold
- $1.2M
- First sale
- Jun 2021
- Incorporated
- Corporation, Washington
- Federal exemptions
- 06b
▶$3.3MraisedNov 2020 · 21 investors · BiotechnologyRule 506(b)
▶$3.3MraisedNov 2020 · 21 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Raymond BartoszekDirector
- Pauline KennyExecutive Officer
- Craig PhilipsExecutive Officer
- Shawn IadonatoExecutive Officer, Director
- Marion R. FooteDirector
- Richard SamuelsonDirector
- Don MerlinoDirector
- Steven MitchellDirector
- Offering amount
- $3.5M
- Amount sold
- $3.3M
- First sale
- Jan 2017
- Incorporated
- Corporation, Washington
- Federal exemptions
- 06b
▶$5MraisedNov 2020 · 1 investors · BiotechnologyRule 506(b)
▶$5MraisedNov 2020 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Shawn IadonatoExecutive Officer, Director
- Craig PhilipsExecutive Officer
- Pauline KennyExecutive Officer
- Marion R. FooteDirector
- Richard SamuelsonDirector
- Don MerlinoDirector
- Raymond BartoszekDirector
- Steven MitchellDirector
- Offering amount
- $5M
- Amount sold
- $5M
- First sale
- Sep 2017
- Incorporated
- Corporation, Washington
- Federal exemptions
- 06b
▶$3MraisedNov 2020 · 9 investors · BiotechnologyRule 506(b)
▶$3MraisedNov 2020 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Shawn ladonatoExecutive Officer, Director
- Craig PhilipsExecutive Officer
- Pauline KennyExecutive Officer
- Marion R. FooteDirector
- Richard SamuelsonDirector
- Don MerlinoDirector
- Raymond BartoszekDirector
- Steven MitchellDirector
- Offering amount
- $3M
- Amount sold
- $3M
- First sale
- Oct 2019
- Incorporated
- Corporation, Washington
- Federal exemptions
- 06b
▶$9MraisedNov 2020 · 2 investors · BiotechnologyRule 506(b)
▶$9MraisedNov 2020 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Shawn IadonatoExecutive Officer, Director
- Craig PhilipsExecutive Officer
- Don MerlinoDirector
- Raymond BartoszekDirector
- Pauline KennyExecutive Officer
- Marion R. FooteDirector
- Steven MitchellDirector
- Richard SamuelsonDirector
- Offering amount
- $9M
- Amount sold
- $9M
- First sale
- Sep 2017
- Incorporated
- Corporation, Washington
- Federal exemptions
- 06b
▶$100KraisedJun 2020 · 1 investors · BiotechnologyRule 506(b)
▶$100KraisedJun 2020 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Richard SamuelsonDirector
- Steven MitchellDirector
- Pauline KennyExecutive Officer
- Craig PhilipsExecutive Officer
- Shawn IadonatoExecutive Officer, Director
- Don MerlinoDirector
- Marion FooteDirector
- Raymond BartoszekDirector
- Offering amount
- $10M
- Amount sold
- $100K
- First sale
- Jun 2020
- Incorporated
- Corporation, Washington
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who founded Kineta?
- Kineta was founded by Shawn Iadonato.
- Who are Kineta's investors?
- Kineta's investors include Wellcome Trust.
- How much funding has Kineta raised?
- Kineta has disclosed $86.2M raised across 18 rounds.
- Where is Kineta headquartered?
- Kineta is headquartered in Seattle, US.